Methylselenocysteine resets the rhythmic expression of circadian and growth-regulatory genes disrupted by nitrosomethylurea in vivo

Cancer Prevention Research

Volumn 3, Issue 5, 2010, Pages 640-652

  Fang, Ming Zhu ^a   Zhang, Xun ^a,c   Zarbl, Helmut ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; CRYPTOCHROME 1; CRYPTOCHROME 2; CYCLIN DEPENDENT KINASE INHIBITOR 1A; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45 ALPHA; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 1 RECEPTOR ALPHA; MESSENGER RNA; METHYLNITROSOUREA; METHYLSELENOCYSTEINE; MYC PROTEIN; PER1 PROTEIN; PER2 PROTEIN; SELENOCYSTEINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG EFFECT; GENE DISRUPTION; GENE EXPRESSION; HORMONE BLOOD LEVEL; LIVER; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

ADMINISTRATION, ORAL; ALKYLATING AGENTS; ANIMALS; ANTICARCINOGENIC AGENTS; BLOTTING, WESTERN; CELL PROLIFERATION; CIRCADIAN RHYTHM; CYSTEINE; DIET; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MAMMARY GLANDS, ANIMAL; METHYLNITROSOUREA; ORGANOSELENIUM COMPOUNDS; RATS; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77952083246     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-09-0170     Document Type: Article

References (53)

1. Fu L, Lee CC. The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer 2003;3:350-361 (Pubitemid 37328855)
2. Chen-Goodspeed M, Lee CC. Tumor suppression and circadian function. J Biol Rhythms 2007;22:291-298
3. Doi M, Hirayama J, Sassone-Corsi P. Circadian regulator CLOCK is a histone acetyltransferase. Cell 2006;125:497-508.
4. Ko CH, Takahashi JS. Molecular components of the mammalian circadian clock. Hum Mol Genet 2006;15:271-277
5. Mackey SR. Biological rhythms workshop IA: Molecular Basis of Rhythms Generation. In: Stillman BSD, Grodzicker T, editors. Cold Spring Harbor Symposia on Quantitative Biology. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 2007, p. 7-19.
6. Balsalobre A. Clock genes in mammalian peripheral tissues. Cell Tissue Res 2002;309:193-199 (Pubitemid 34744041)
7. Shim HS, Kim H, Lee J, et al. Rapid activation of CLOCK by Ca2+-dependent protein kinase C mediates resetting of the mammalian circadian clock. EMBO Rep 2007;8:366-371 (Pubitemid 46511037)
8. De Leersnyder H, Bresson JL, de Blois MC, et al. β1-Adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome. J Med Genet 2003;40:74-78 (Pubitemid 36115131)
9. Liu C, Weaver DR, Jin X, et al. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 1997;19:91-102. (Pubitemid 27332996)
10. Hamilton T. Influence of environmental light and melatonin upon mammary tumour induction. Br J Surg 1969;56:764-766
11. Aubert C, Janiaud P, Lecalvez J. Effect of pinealectomy and melatonin on mammary tumor growth in Sprague-Dawley rats under different conditions of lighting. J Neural Transm 1980;47:121-130 (Pubitemid 10179967)
12. Gery S, Gombart AF, Yi WS, Koeffler C, Hofmann WK, Koeffler HP. Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia. Blood 2005;106:2827-2836 (Pubitemid 41510760)
13. Hua H, Wang Y, Wan C, et al. Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci 2006;97:589-596 (Pubitemid 44056606)
14. Canaple L, Kakizawa T, Laudet V. The days and nights of cancer cells. Cancer Res 2003;63:7545-7552
15. Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 2005;26:1241-1246
16. Yeh KT, Yang MY, Liu TC, et al. Abnormal expression of period 1 (PER1) in endometrial carcinoma. J Pathol 2005;206:111-120 (Pubitemid 40613441)
17. Yang MY, Chang JG, Lin PM, et al. Downregulation of circadian clock genes in chronic myeloid leukemia: alternative methylation pattern of hPER3. Cancer Sci 2006;97:1298-1307
18. Stevens RG. Circadian disruption and breast cancer: from melatonin to clock genes. Epidemiology 2005;16:254-258 (Pubitemid 40314419)
19. Clark LC, Combs GF, Jr., Turnbull BW, et al. Nutritional Prevention of Cancer Study Group. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. JAMA 1996;276:1957-1963
20. El-Bayoumy K, Sinha R. Mechanisms of mammary cancer chemoprevention by organoselenium compounds. Mutat Res 2004;551:181-197 (Pubitemid 38833507)
21. Jackson MI, Combs GF, Jr. Selenium and anticarcinogenesis: underlying mechanisms. Curr Opin Clin Nutr Metab Care 2008;11:718-726
22. Medina D, Thompson H, Ganther H, Ip C. Se-methylselenocysteine: a new compound for chemoprevention of breast cancer. Nutr Cancer 2001;40:12-17 (Pubitemid 34037509)
23. Zhang X, Zarbl H. Chemopreventive doses of methylselenocysteine alter circadian rhythm in rat mammary tissue. Cancer Prev Res 2008;1:119-127
24. Fang MZ, Chen D, Sun Y, Jin Z, Christman JK, Yang CS. Reversal of hypermethylation and reactivation of p16INK4a, RARβ, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res 2005;11:7033-7041
25. Fang MZ, Jin Z, Wang Y, et al. Promoter hypermethylation and inactivation of O(6)-methylguanine-DNA methyltransferase in esophageal squamous cell carcinomas and its reactivation in cell lines. Int J Oncol 2005;26:615-622
26. Iurisci I, Filipski E, Reinhardt J, et al. Improved tumor control through circadian clock induction by Seliciclib, a cyclin-dependent kinase inhibitor. Cancer Res 2006;66:10720-10728 (Pubitemid 44876967)
27. Pandi-Perumal SR, Trakht I, Srinivasan V, et al. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol 2008;85:335-353
28. Stehle JH, von Gall C, Korf HW. Melatonin: a clock-output, a clock-input. J Neuroendocrinol 2003;15:383-389
29. Cai W, Rambaud J, Teboul M, et al. Expression levels of estrogen receptor β are modulated by components of the molecular clock. Mol Cell Biol 2008;28:784-793
30. Cos S, Gonzalez A, Martinez-Campa C, Mediavilla MD, Alonso-Gonzalez C, Sanchez-Barcelo EJ. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions. Cancer Detect Prev 2006;30:118-128 (Pubitemid 43766230)
31. Gery S, Virk RK, Chumakov K, Yu A, Koeffler HP. The clock gene Per2 links the circadian system to the estrogen receptor. Oncogene 2007;26:7916-7920 (Pubitemid 350262755)
32. Horard B, Rayet B, Triqueneaux G, Laudet V, Delaunay F, Vanacker JM. Expression of the orphan nuclear receptor ERRα is under circadian regulation in estrogen-responsive tissues. J Mol Endocrinol 2004;33:87-97. (Pubitemid 39206350)
33. Stokkan KA, Yamazaki S, Tei H, Sakaki Y, Menaker M. Entrainment of the circadian clock in the liver by feeding. Science 2001;291:490-493 (Pubitemid 32097074)
34. Jilg A, Moek J, Weaver DR, Korf HW, Stehle JH, von Gall C. Rhythms in clock proteins in the mouse pars tuberalis depend on MT1 melatonin receptor signalling. Eur J Neurosci 2005;22:2845-2854 (Pubitemid 41811282)
35. von Gall C, Weaver DR, Moek J, Jilg A, Stehle JH, Korf HW. Melatonin plays a crucial role in the regulation of rhythmic clock gene expression in the mouse pars tuberalis. Ann N Y Acad Sci 2005;1040:508-511 (Pubitemid 40979855)
36. Witt-Enderby PA, Radio NM, Doctor JS, Davis VL. Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy. J Pineal Res 2006;41:297-305.
37. Nakahata Y, Kaluzova M, Grimaldi B, et al. The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 2008;134:329-340 (Pubitemid 352010336)
38. Rutter J, Reick M, Wu LC, McKnight SL. Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors. Science 2001;293:510-514 (Pubitemid 32679080)
39. Jin Z, Houle B, Mikheev AM, Cha RS, Zarbl H. Alterations in H-ras1 promoter conformation during N-nitroso-N-methylurea-induced mammary carcinogenesis and pregnancy. Cancer Res 1996;56:4927-4935 (Pubitemid 26374431)
40. Zarbl H. Toxicogenomic analyses of genetic susceptibility to mammary gland carcinogenesis in rodents: implications for human breast cancer. Breast Dis 2007;28:87-105. (Pubitemid 350187028)
41. Xiang N, Zhao R, Song G, Zhong W. Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells. Carcinogenesis 2008;29:2175-2181
42. Tsukamoto R, Mikami T, Miki K, et al. N-methyl-N-nitrosourea-induced mammary carcinogenesis is promoted by short-term treatment with estrogen and progesterone mimicking pregnancy in aged female Lewis rats. Oncol Rep 2007;18:337-342
43. Williams C, Edvardsson K, Lewandowski SA, Strom A, Gustafsson JA. A genome-wide study of the repressive effects of estrogen receptor β on estrogen receptor α signaling in breast cancer cells. Oncogene 2008;27:1019-1032 (Pubitemid 351225390)
44. Matthews J, Gustafsson JA. Estrogen signaling: a subtle balance between ERα and ERβ. Mol Interv 2003;3:281-292
45. Oklejewicz M, Destici E, Tamanini F, Hut RA, Janssens R, van der Horst GT. Phase resetting of the mammalian circadian clock by DNA damage. Curr Biol 2008;18:286-291
46. Kondratov RV, Antoch MP. Circadian proteins in the regulation of cell cycle and genotoxic stress responses. Trends Cell Biol 2007;17:311-317 (Pubitemid 47102196)
47. Hansen J. Increased breast cancer risk among women who work predominantly at night. Epidemiology 2001;12:74-77 (Pubitemid 32006465)
48. Monsen ER. Dietary reference intakes for the antioxidant nutrients: vitamin C, vitamin E, selenium, and carotenoids. J Am Diet Assoc 2000;100:637-640
49. Yang G, Zhou R. Further observations on the human maximum safe dietary selenium intake in a seleniferous area of China. J Trace Elem Electrolytes Health Dis 1994;8:159-165
50. Combs GF, Jr. Impact of selenium and cancer-prevention findings on the nutrition-health paradigm. Nutr Cancer 2001;40:6-11.
51. Orzano AJ, Strickland PO, Tallia AF, et al. Improving outcomes for high-risk diabetics using information systems. J Am Board Fam Med 2007;20:245-251
52. Tsavachidou D, McDonnell TJ, Wen S, et al. Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst 2009;101:306-320
53. Orzano AJ, Scott J, Hudson SV, et al. Strategies for conducting complex clinical trials in diverse community practices. Med Care 2007;45:1221-1226